BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Renovis

Renovis

Renovis is a biopharmaceutical company developing drugs to treat neurological diseases and disorders. Renovis' current focus is on research and development programs in the areas of neuroprotection, pain, and neuroinflammatory diseases. Their most advanced candidate is Cerovive®, an intravenous drug being evaluated for the treatment of acute ischemic stroke

 

PRODCUT PIPELINE CHART

 

CLINICAL TRIALS

Cerovive for the treatment of acute ischemic stroke

REN-1654 l for the treatment of sciatica, a form of neuropathic pain

REN-850 for the treatment of multiple sclerosis and other autoimmune diseases



More About Renovis

Home ge

Key Statistics for Renovis

Basic Chart for Renovis

Analyst Opinion

Analysts Estimates

 
Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright © 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com